Literature DB >> 7196769

Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment.

W J McKenna, L Harris, G Perez, D M Krikler, C Oakley, J F Goodwin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7196769      PMCID： PMC482624          DOI： 10.1136/hrt.46.2.173

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  18 in total

1.  Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment.

Authors:  S B Olsson; L Brorson; E Varnauskas
Journal:  Br Heart J       Date:  1973-12

2.  Prognosis and mortality of hypertrophic obstructive cardiomyopathy.

Authors:  T Hardarson; C S De la Calzada; R Curiel; J F Goodwin
Journal:  Lancet       Date:  1973-12-29       Impact factor: 79.321

3.  Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.

Authors:  D R Rosing; K M Kent; B J Maron; S E Epstein
Journal:  Circulation       Date:  1979-12       Impact factor: 29.690

4.  Treatment of hypertrophic obstructive cardiomyopathy with verapamil.

Authors:  M Kaltenbach; R Hopf; G Kober; W D Bussmann; M Keller; Y Petersen
Journal:  Br Heart J       Date:  1979-07

5.  M mode echocardiography in hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction.

Authors:  Y L Doi; W J McKenna; J Gehrke; C M Oakley; J F Goodwin
Journal:  Am J Cardiol       Date:  1980-01       Impact factor: 2.778

6.  Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy.

Authors:  D D Savage; S F Seides; B J Maron; D J Myers; S E Epstein
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690

7.  "Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death.

Authors:  B J Maron; L C Lipson; W C Roberts; D D Savage; S E Epstein
Journal:  Am J Cardiol       Date:  1978-06       Impact factor: 2.778

8.  Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.

Authors:  E Rowland; D M Krikler
Journal:  Br Heart J       Date:  1980-07

9.  Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy.

Authors:  W J McKenna; S Chetty; C M Oakley; J F Goodwin
Journal:  Am J Cardiol       Date:  1980-01       Impact factor: 2.778

10.  Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation.

Authors:  B J Maron; W C Roberts; J E Edwards; H A McAllister; D D Foley; S E Epstein
Journal:  Am J Cardiol       Date:  1978-05-01       Impact factor: 2.778
View more
  19 in total

Review 1.  Obstruction is unimportant in the pathophysiology of hypertrophic cardiomyopathy.

Authors:  J M Criley; R J Siegel
Journal:  Postgrad Med J       Date:  1986-06       Impact factor: 2.401

Review 2.  The frontiers of cardiomyopathy.

Authors:  J F Goodwin
Journal:  Br Heart J       Date:  1982-07

Review 3.  Assessment of the risk-benefit ratio for antiarrhythmic drug use.

Authors:  R W Campbell
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 4.  Electrophysiological disturbances in heart failure.

Authors:  R W Campbell
Journal:  Br Heart J       Date:  1994-08

Review 5.  Amiodarone: the experience of the past decade.

Authors:  W J McKenna; E Rowland; D M Krikler
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03

Review 6.  Potential mechanisms of improvement after various treatments for hypertrophic obstructive cardiomyopathy.

Authors:  R D Leachman
Journal:  Tex Heart Inst J       Date:  1995

Review 7.  Verapamil in arrhythmia.

Authors:  D M Krikler
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

8.  Haemodynamic effects of short term intravenous amiodarone for hypertrophic cardiomyopathy.

Authors:  A Branzi; C Rapezzi; P M Benenati; G Binetti; G Piovaccari; M Bacchi; R Roncuzzi; R Zannoli; B Magnani
Journal:  Br Heart J       Date:  1988-04

9.  Syncope in hypertrophic cardiomyopathy.

Authors:  W McKenna; L Harris; J Deanfield
Journal:  Br Heart J       Date:  1982-02

10.  Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function.

Authors:  D M Anderson; G L Raff; T A Ports; B H Brundage; W W Parmley; K Chatterjee
Journal:  Br Heart J       Date:  1984-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.